Meray Serdar

Meray Serdar studied biochemistry and completed a master’s degree in electrophysiology. In 2012, she began her PhD at the Department of Pediatrics I/Neonatology & Experimental Perinatal Neurosciences at University Hospital Essen, under the supervision of Professor Ivo Bendix and Professor Ursula Felderhoff-Müser. Their research investigated hyperoxia-induced preterm brain injury and the effects of fingolimod in vivo and in vitro. Since 2017, Meray has been a postdoctoral researcher in the same lab, focusing on developing a clinically relevant experimental model for preterm brain injury, incorporating prenatal inflammation and postnatal hyperoxia. Their current research examines the potential of intranasal mesenchymal stem cell (MSC) therapy as a treatment.